Mission Bio
South San Francisco, US · Founded 2014 · 91 employees on LinkedIn · 9 known investors
Find your way into Mission Bio
Sign up to see every warm intro you have to Mission Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Mission Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Mission Bio develops single-cell biology tools and platforms for researchers and clinicians to enable precision medicine discovery and cancer treatment. The company serves the biomedical research and clinical diagnostics market.
Founders & leadership
Mission Bio was founded in 2014 by Adam Sciambi and Adam Abate, Ph.D..
Board
Investors · 9
How we know: av.vc · Not right? Tell us
How we know: Cota Capital's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Green Park & Golf Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Keiretsu Forum's portfolio page · Not right? Tell us
How we know: Mighty Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$41.7M disclosed across 2 rounds · 2017–2018
▶$28.4MraisedJul 2018 · 32 investors · BiotechnologyRule 506(b)
- Brock Siegel, Ph.D.Director
- Adam Abate, Ph.D.Director
- Maneesh Jain, Ph.D.Director
- Allison BallmerDirector
- Paul Billings, M.D., Ph.D.Director
- Charles SilverExecutive Officer, Director
- Urshit ParikhDirector
- Offering amount
- $30M
- Amount sold
- $28.4M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13.3MraisedJun 2017 · 54 investors · BiotechnologyRule 506(b)
- Paul Billings, M.D., Ph.D.Director
- Urshit ParikhDirector
- Charles SilverExecutive Officer, Director
- Maneesh Jain, Ph.D.Director
- Adam Abate, Ph.D.Director
- Brock Siegel, Ph.D.Director
- Offering amount
- $13.3M
- Amount sold
- $13.3M
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Companies working in the same space as Mission Bio.
Frequently asked questions
- What does Mission Bio do?
- Mission Bio develops single-cell biology tools and platforms for researchers and clinicians to enable precision medicine discovery and cancer treatment. The company serves the biomedical research and clinical diagnostics market.
- Who founded Mission Bio?
- Mission Bio was founded by Adam Sciambi, Adam Abate, Ph.D. in 2014.
- Who are Mission Bio's investors?
- Mission Bio's investors include Alumni Ventures, Cota Capital, Fusion, Green Park & Golf Ventures, Keiretsu Forum, Mighty Capital, Sand Hill Angels, Seabed VC and 1 more.
- How much funding has Mission Bio raised?
- Mission Bio has disclosed $41.7M raised across 2 rounds.
- Where is Mission Bio headquartered?
- Mission Bio is headquartered in South San Francisco, US.







